<p>Provided are compounds of Formula (I) and (II) and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and their use for treating viral infections mediated by a member of the Flaviviridae family of viruses such as hepatitis C virus (HCV).</p>
申请公布号
WO2011097491(A1)
申请公布日期
2011.08.11
申请号
WO2011US23763
申请日期
2011.02.04
申请人
GLAXOSMITHKLINE LLC;BANKA, ANNA;CATALANO, JOHN G;FANG, JING;PEAT, ANDREW JAMES;TAI, VINCENT;TURNER, ELIZABETH
发明人
BANKA, ANNA;CATALANO, JOHN G;FANG, JING;PEAT, ANDREW JAMES;TAI, VINCENT;TURNER, ELIZABETH